{"ticker": {"uuid": "3a020e5f-8ee0-4024-ba2f-049a525d9fd1", "symbol": "MGRX", "name": "Mangoceuticals, Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Health Information Services"}, "articles": [{"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Mangoceuticals, Inc. \u2013 BOATS:MGRX", "summary": "This article provides financial information for Mangoceuticals, Inc. (MGRX), specifically focusing on its forward price-to-sales ratio. It appears to be a stub or a data-focused page from TradingView, indicating no trades and a closed market for the stock at the time of publicati", "url": "https://www.tradingview.com/symbols/BOATS-MGRX/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-12T20:11:13", "published_display": "12 Jul 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Mangoceuticals, Inc. \u2013 NASDAQ:MGRX", "summary": "This article provides the enterprise value to EBITDA forward for Mangoceuticals, Inc. (NASDAQ: MGRX) as displayed on TradingView. It highlights key financial metrics for MGRX, a company in the Pharmaceuticals: Major sub-sector. The data is supported by various financial and refer", "url": "https://www.tradingview.com/symbols/NASDAQ-MGRX/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T07:41:36", "published_display": "07 Jul 2026 07:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Mangoceuticals, Inc. \u2013 NASDAQ:MGRX", "summary": "The article presents the \"price to earnings forward\" metric for Mangoceuticals, Inc. (NASDAQ: MGRX). It shows the period, value, change, and percentage change for this financial indicator. The content is primarily a data display from TradingView, including various navigation and ", "url": "https://www.tradingview.com/symbols/NASDAQ-MGRX/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T09:10:35", "published_display": "06 Jul 2026 09:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Mangoceuticals, Inc. \u2013 NASDAQ:MGRX", "summary": "This article displays the title \"Enterprise value to revenue forward of Mangoceuticals, Inc. \u2013 NASDAQ:MGRX\" and some basic financial and market navigation information for Mangoceuticals, Inc. (MGRX). It shows that the market is closed with no trades, and provides links to overvie", "url": "https://www.tradingview.com/symbols/NASDAQ-MGRX/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T03:09:35", "published_display": "06 Jul 2026 03:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Mangoceuticals, Inc. Stocks", "summary": "This article lists ETFs that include Mangoceuticals, Inc. (MGRX) stocks in their holdings. It provides details on one specific ETF, the E Fund CSI Shanghai-Hong Kong-Shenzhen 500 ETF, including its market value, weight of MGRX, expense ratio, and performance. The information aims", "url": "https://www.tradingview.com/symbols/NASDAQ-MGRX/etfs/", "source_name": "TradingView", "published_at": "2026-07-04T03:11:10", "published_display": "04 Jul 2026 03:11", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals (MGRX) completes $272,000 private placement of common shares", "summary": "Mangoceuticals, Inc. (MGRX) has completed a private placement, selling 850,000 shares of restricted common stock to an accredited investor at $0.32 per share, totaling $272,000. The transaction, disclosed in an 8-K filing, includes piggyback registration rights for the investor f", "url": "https://www.stocktitan.net/sec-filings/MGRX/8-k-mangoceuticals-inc-reports-material-event-b680cbd4e52b.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:40:10", "published_display": "02 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals, Inc. announced that it has received $0.272 million in funding", "summary": "Mangoceuticals, Inc. has secured $0.272 million in funding through a subscription agreement with an accredited investor. The company issued 850,000 shares of restricted common stock at $0.32 per share, availing an exemption from registration under the securities act. This funding", "url": "https://www.marketscreener.com/news/mangoceuticals-inc-announced-that-it-has-received-0-272-million-in-funding-ce7f5fd3d181f423", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T16:11:10", "published_display": "29 Jun 2026 16:11", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trending Stocks Today | Mangoceuticals Soars 41.16% Post-Market", "summary": "Mangoceuticals (OTC: MNGOC) stock saw a significant 41.16% increase in post-market trading today, reaching $0.0031. This surge occurred despite the company not releasing any specific news or updates, suggesting market speculation or technical trading movements as potential driver", "url": "https://www.moomoo.com/news/post/71848625/trending-stocks-today-mangoceuticals-soars-41-16-post-market", "source_name": "Moomoo", "published_at": "2026-06-22T21:09:54", "published_display": "22 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MGRX Q3 2025 Earnings: EPS Loss of $0.69; Stock Declines 4.61% Amid Limited Data - Financial Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNcHlwa2xlNVN0X0Jqa2ROcUFqUEtneVhqWDhIYUxYUFIxa3ZvMk5iNWluWEVWRjF4MGFuT0VzMlE5ODVUeVBmZ2VUd2Rtb0VWYjZWYWFHSE1kTlZPLUMyTTROS1ZJUWNtLUtJdFdocnVhekdrN3BMa0NiYm1DUzBJb0xMNklJUVZIXzk1VDNEOEhLaEZ2emV6MWppWmdiYVk0enhnazAzaGpzWTZfRU9vRVctbXFndjlfM2htT2x0SjdGZw?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals Inc (MGRX) Institutional Confidence", "summary": "This article from TradingKey provides an overview of institutional confidence in Mangoceuticals Inc (MGRX), including its stock price, market cap, and various analytical dimensions. It details the institutional shareholding, listing key holders like Armistice Capital LLC and Cohe", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mgrx/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T21:40:39", "published_display": "18 Jun 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals Inc (MGRX) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "The article provides an overview of Mangoceuticals Inc (MGRX) stock, focusing on its dividend history and stock split events. It indicates that MGRX has not distributed dividends in the past five years and lists several merger events scheduled for October 11, 2024, with a 15:1 ra", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mgrx/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T13:10:22", "published_display": "17 Jun 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals Inc (MGRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article from TradingKey provides a revenue breakdown for Mangoceuticals Inc (MGRX), though it states that relevant data regarding business segments, regional revenue, and profit contribution have not yet been disclosed by the company. It briefly shows the stock's current mar", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mgrx/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T12:10:22", "published_display": "17 Jun 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MGRX Q3 2025 Earnings: Loss Per Share Pressures Stock as Revenue Remains Undisclosed - Peak Earnings Alert", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQakhtUm9DZlRSMGFJeFV6cThXb29EcGZSUFI4VXJBX2xUT1B5eVR3Zm9ZV25ndXhoaEFFTjNacnpXWTRya1l2YmxjVjlrVU1jQzhnbFBsSkt3MVN1YTROeEZVYlZZWXVlczFDZ3hJX2phX0NjeHJyVXdvSnRpNDNjY0owSHJWa3IwUTA4VVlDUVk0RFVDY0pRQ0hrMXVrWk1SbmlqSEZYT1p0aU9POXFONkZCRHhKX3V1VGdZZk1WV1lBSTg?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals (Nasdaq:MGRX) - Stock Analysis", "summary": "Mangoceuticals, Inc. (Nasdaq:MGRX) is a company specializing in men's wellness products and services delivered via a telemedicine platform. The stock analysis highlights significant risks including shareholder dilution, declining earnings and revenue, a small market capitalizatio", "url": "https://simplywall.st/stocks/us/consumer-retailing/nasdaq-mgrx/mangoceuticals", "source_name": "Simply Wall Street", "published_at": "2026-06-03T15:40:30", "published_display": "03 Jun 2026 15:40", "sentiment": "negative", "sentiment_pct": 8, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MGRX - Mangoceuticals Inc Stock Price and Quote", "summary": "This article provides a detailed overview of Mangoceuticals Inc. (MGRX) stock, including its current price, financial metrics, performance indicators, and recent news headlines. It covers market capitalization, sales, earnings per share, insider transactions, and a chronological ", "url": "https://finviz.com/stock?t=MGRX", "source_name": "Finviz", "published_at": "2026-06-01T15:10:35", "published_display": "01 Jun 2026 15:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MGRX Technical Analysis & Stock Price Forecast", "summary": "This article provides a technical analysis and stock price forecast for Mangoceuticals Inc (MGRX) as of June 1, 2026. It indicates an overall Neutral technical sentiment based on various indicators, with some suggesting buy and others sell. The analysis covers moving averages, mo", "url": "https://intellectia.ai/en/stock/MGRX/technical", "source_name": "Intellectia AI", "published_at": "2026-06-01T14:09:46", "published_display": "01 Jun 2026 14:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrightSpring Health Services (BTSG) Stock Analysis: Exploring Growth Amidst Strong Revenue Surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxORE9OaWtsRXhXVG1pb1k1OE55LTR4RXBWbUthTDBzSUMwdEZZcGdhUHNQdmFQeWIwbUlsYWNGZlVHVnNQTFF1Z0ZTUXBmME5tOVI1UjRtbTBkMC1Gc092TFRRUGpRaXJmMnhSTWRFS1FCYkIyeU1FbU5Hc1ZjOGtOZENWOUJuSEdjbGJIQjBPZmNhSy1GRVh1bTRDd0JKLWN3U0VoQi1YZEpjcTBKaUFvMzRxSENzUjdSR1VjT3o3V1gySXJXTHVTdzhzQ1NjWEMybnRNVHJIby1YanRt?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Number of shareholders of Mangoceuticals, Inc. \u2013 NASDAQ:MGRX", "summary": "This article displays the number of shareholders for Mangoceuticals, Inc. (NASDAQ: MGRX) as retrieved from TradingView. It provides a quick overview, but the specific numerical value for shareholders is not explicitly stated in the provided content. The article is part of Trading", "url": "https://www.tradingview.com/symbols/NASDAQ-MGRX/financials-statistics-and-ratios/number-of-shareholders/", "source_name": "TradingView", "published_at": "2026-05-30T17:08:53", "published_display": "30 May 2026 17:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals (NASDAQ: MGRX) Q1 2026 shows small sales, heavy loss and thin cash", "summary": "Mangoceuticals Inc. reported a Q1 2026 net loss of $3.4 million on revenues of $67,864, down from the prior year, with significant spending on operations and stock-based compensation. The company's cash and cash equivalents dwindled to $174,562, highlighting severe liquidity conc", "url": "https://www.stocktitan.net/sec-filings/MGRX/10-q-mangoceuticals-inc-quarterly-earnings-report-f99fc656b57e.html", "source_name": "Stock Titan", "published_at": "2026-05-20T08:39:50", "published_display": "20 May 2026 08:39", "sentiment": "negative", "sentiment_pct": 15, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MANGOCEUTICALS, INC. 1Q 2026: Revenue $67.9K, EPS $(0.22) \u2014 10-Q Summary", "summary": "MANGOCEUTICALS, INC. (MGRX) reported its first-quarter 2026 results, showing a revenue of $67.9K, a decrease from the prior year, and a net loss of $3.7M. Despite the revenue decline, the company narrowed its loss per share to $(0.22). Key business activities included advancing w", "url": "https://www.tradingview.com/news/tradingview:c76bab4add3ea:0-mangoceuticals-inc-1q-2026-revenue-67-9k-eps-0-22-10-q-summary/", "source_name": "TradingView", "published_at": "2026-05-19T20:39:50", "published_display": "19 May 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MGRX: Net loss narrowed but liquidity and Nasdaq compliance risks persist, requiring urgent funding", "summary": "MGRX experienced a decline in revenue and a narrowed net loss year-over-year, attributed to its focus on product testing and website development. However, the company faces ongoing financial losses, regulatory challenges, and Nasdaq compliance issues, underscoring an urgent need ", "url": "https://www.tradingview.com/news/urn:summary_document_report:quartr.com:3349304:0-mgrx-net-loss-narrowed-but-liquidity-and-nasdaq-compliance-risks-persist-requiring-urgent-funding/", "source_name": "TradingView", "published_at": "2026-05-19T20:39:50", "published_display": "19 May 2026 20:39", "sentiment": "negative", "sentiment_pct": 20, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals Delays Quarterly Filing After Audit Review", "summary": "Mangoceuticals, Inc. (MGRX) has announced a delay in filing its Form 10-Q for the quarter ended March 31, 2026, due to additional time required by its independent auditor for review. The company expects to file within the five-day grace period and does not anticipate significant ", "url": "https://www.tipranks.com/news/company-announcements/mangoceuticals-delays-quarterly-filing-after-audit-review", "source_name": "TipRanks", "published_at": "2026-05-15T23:09:11", "published_display": "15 May 2026 23:09", "sentiment": "negative", "sentiment_pct": 39, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals stock doubles after Texas lawsuit", "summary": "Mangoceuticals (MNGO) stock surged by an unspecified percentage following a legal victory in Texas. The company announced the successful resolution of its lawsuit against its former Chief Executive Officer. This news led to a significant increase in investor confidence and the st", "url": "https://www.msn.com/en-us/money/news/mangoceuticals-stock-doubles-after-texas-lawsuit/ar-AA1ZeNdH", "source_name": "MSN", "published_at": "2026-04-14T16:09:36", "published_display": "14 Apr 2026 16:09", "sentiment": "positive", "sentiment_pct": 95, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MGRX Q4 2025 Earnings Report on 4/1/2026", "summary": "This article details the Q4 2025 earnings report for Mangoceuticals (NASDAQ: MGRX), released on April 1, 2026. The company reported $0.13 Actual EPS and $0.09 million in Actual Revenue, with both consensus EPS and expected revenue listed as N/A. The report also highlights recent ", "url": "https://www.marketbeat.com/earnings/reports/2026-4-1-mangoceuticals-inc-stock/", "source_name": "MarketBeat", "published_at": "2026-04-01T13:39:44", "published_display": "01 Apr 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals 10-K: Revenue $0.456M, EPS loss $(2.17)", "summary": "Mangoceuticals (MGRX) reported annual revenue of $0.456 million and an EPS loss of $(2.17) for the year, primarily due to issues during a telemedicine platform relaunch. The company posted a significant net loss of $(20.643) million, driven by increased stock-based compensation, ", "url": "https://www.tradingview.com/news/tradingview:d1fb628062618:0-mangoceuticals-10-k-revenue-0-456m-eps-loss-2-17/", "source_name": "TradingView", "published_at": "2026-04-01T10:10:10", "published_display": "01 Apr 2026 10:10", "sentiment": "negative", "sentiment_pct": 30, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals Delays Annual 10-K Yearly Filing", "summary": "Mangoceuticals, Inc. (MGRX) has announced a delay in filing its 2025 Form 10-K Yearly Report, attributing the hold-up to its external auditor needing additional time for review. The company expects to file within the 15-day grace period from the original March 31, 2026 due date a", "url": "https://www.tipranks.com/news/company-announcements/mangoceuticals-delays-annual-10-k-yearly-filing", "source_name": "TipRanks", "published_at": "2026-04-01T02:10:10", "published_display": "01 Apr 2026 02:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MGRX SEC Filings - Mangoceuticals, Inc. 10-K, 10-Q, 8-K Forms", "summary": "This page on Stock Titan provides comprehensive access to Mangoceuticals, Inc. (MGRX) SEC filings, including annual reports (10-K), quarterly earnings (10-Q), and material events (8-K), along with insider trading forms. It details recent filings such as 8-K reports on stock place", "url": "https://www.stocktitan.net/sec-filings/MGRX/page-3.html", "source_name": "Stock Titan", "published_at": "2026-03-30T05:38:59", "published_display": "30 Mar 2026 05:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MGRX Mangoceuticals (NASDAQ) pre-market +99.81% Mar 24, 2026: watch heavy volume", "summary": "Mangoceuticals (MGRX) stock saw a significant pre-market surge of nearly 100% on heavy volume, driven by a recent patent filing, a lawsuit announcement, and strong retail interest. Despite this price action, the company's fundamentals indicate negative EPS and weak operating cash", "url": "https://meyka.com/blog/mgrx-mangoceuticals-nasdaq-pre-market-9981-mar-24-2026-watch-heavy-volume-2403/", "source_name": "Meyka", "published_at": "2026-03-24T09:10:08", "published_display": "24 Mar 2026 09:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals (MGRX) Stock Rockets 130% Following CEO\u2019s Substantial Share Award", "summary": "Shares of Mangoceuticals (MGRX) surged over 129% after SEC filings revealed CEO Jacob Cohen received a 500,000-share bonus and transferred an additional 200,000 shares to The Tiger Cub Trust. This comes amid exploding trading volumes and significant company activity including lit", "url": "https://www.mexc.com/news/974922", "source_name": "MEXC", "published_at": "2026-03-23T22:38:58", "published_display": "23 Mar 2026 22:38", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$MGRX stock is up 74% today. Here's what we see in our data.", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPd05VcFhmc3dYeHR4eV9HeGpHQXNheERXVk5wTzl1MjlvcnZYNm84dzJSbFI0aWpoall4WHNkWndKektDUEhHQ1JrX19ydHdpNWs4eXF3dkkwYjlMZ3owR1QxbndmRzdUMGx6QjhhUmRzQS1ucGthUzJqbHQ2UW9ta3RSVFpKeGxkY3V2UGZhZnhqLUZrYkJNX1JfY0g4REk2?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-02-20T08:00:00+00:00", "published_display": "20 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isn\u2019t the Only Problem.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPMTdzUkZQWG9tTW9zT3FxSWtzdkdLLUNYVkRJMDh2X1VRSlVrdmVkS3FCSVFpX210VUxVSUF1Q2FYakw1ZUxyQlpoZHZpM1RYQzBOYlpEWENxeGM1bXBZNFYxQjZRcFBpcS0tVVhRdzFTejBrVzU3aU9QQXdnYkZBMWxB?oc=5", "source_name": "Barron's", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxNQWRfTUpZV1VMWS0yT1pHZ2o3bmpPbWF2TnhCYldBUExuUmI5UnRZUGVVRGxDWTVveUlZZUo5Vm4wWE5md2k2Skt5YTlEVmJJV2pydWNrMFctTW9PSjFvekdqclhrSFpJYm5vVkQ4cjJlSi1BUV84ZjRBZlcyMFFQUW5zc1o?oc=5", "source_name": "Market source", "published_at": "2025-12-18T08:00:00+00:00", "published_display": "18 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals stock tumbles after Novo Nordisk, Lilly deny partnership claims", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQZEFuUzFWVFk3bGNrbDJVc0UyNHpvYUhSaXFNdC1TbW1CTGpFRUpTc21femZtV0JFMERQWVowSERQVVk2dl90MF9INDNzSmZBN1hiOC1WYV9kTTlqcVdOWVhpT1BoSmMtQVkxeTVTMXhwRFVWZWJKd1dwQkVva2stVkhJaFVZZVEyb0gyMGlWSTllQWlGeFhKdVFsbVBZVm01ZlZ4QndKLU9wTTB0NHl4UjAteWxGOV9vclViYnRIbVpJYWt3STF0VXEtdW5Iak1iX203aXl3?oc=5", "source_name": "Investing.com", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eco Science (ESSI) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5pdzBTRmxWRF9FdWNNTm9zUHp3cGVyeUtkRjNscHJKRWx0cUNkb2t5VTVsNXBNNDBXb3l2Qko1OXo2NXRfc0E5SjlvTVRyLUoycmlv?oc=5", "source_name": "Stock Titan", "published_at": "2025-09-18T22:26:50+00:00", "published_display": "18 Sep 2025 22:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TruBridge (TBRG) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBTeUEyaURoX1pUeXB4SEpSazZmal9VbGF2Qm8yWkVQZ2MwT3NzQTZkalRTRjdKcWM1YVA3TXpFOC1ZQ2lUWjdsM0QtNGFlNlhrLW1V?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T01:29:21+00:00", "published_display": "25 Apr 2025 01:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "VSee Health (VSEE) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE0ydzh1bEdnSnNlUEItUk5hZ0dGaV9yS2dscmFDa2tpT1ZFaGkwbzhLdUt3N3pfTnpHRlNVNE85N2J3cm4yajI4Zk9YbFpObW5aSnJV?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T18:07:28+00:00", "published_display": "24 Apr 2025 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Health Catalyst (HCAT) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9nVmdOdTFQYkVyaHJ6UW1DUWlITUZGdXlFY0l3dnZiNTk5djRlSFN0RFJkUHZ5RTMtU0VBMkJyZy1qb3ZsLUFyUmdFdWhiMDNaaVAw?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T17:33:44+00:00", "published_display": "24 Apr 2025 17:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Privia Health Group (PRVA) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFB2Z196b3pOYmd5QVVPUU9UakxZWllvaXozczRjR1lhaTh3eDBLS2NvcUhEU3g2TkxXNDh5SFg0a2ZXWkc4amZTRzc1QnJUM0hFRlFz?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T17:25:31+00:00", "published_display": "24 Apr 2025 17:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQUVQ0NVdGRzZjQXY5ZUdhVEFDbGVDaVdUbkd2bHhsdVZBMUx0T3NWMmVCUVhUMGRRNkdyaEtWeXpsR3FqY00wZlFqOU5DTkszUzQ2TWVCdWU3dzJCeWlXTzc1UURFZTZUWUtwQVM2MEJDSUtZQUhNZ0RvRnpXMENFbkZMWXMyVlhVQVVTclJwNVlHdjlyYWhIREJmOGJYbFE?oc=5", "source_name": "Market source", "published_at": "2024-12-04T08:00:00+00:00", "published_display": "04 Dec 2024 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "VSee Health (VSEE) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE9kdkZWQUJKUU1kT1hZb05MR2N1WmlnNktpY0Y1UDRJV3c3bWRtaU5QVEh4ZTZxbGF0TTdxTUFmSkh0cXR0UXpuM0xiNURCdw?oc=5", "source_name": "Stock Titan", "published_at": "2024-06-27T12:22:07+00:00", "published_display": "27 Jun 2024 12:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE1ZWGVRQlRLUEtvLTJIN01QMld5a3lpMnZSUWpjbzlrZWtqT0piN2c4U1BiVktEdm1pSTRTUnV2c1pPaTJvaDZEZ2xjVGpFeGZk?oc=5", "source_name": "CNN", "published_at": "2023-12-18T16:28:09+00:00", "published_display": "18 Dec 2023 16:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MGRX Stock Price and Chart \u2014 NASDAQ:MGRX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE4zZ1BXc2ZULWF4NE1tVjRxcG1VM0tiZmJVQ0ktb1k1LXlqaGNyV2lncldwcUVrRTg2Zml2TmRXWFpmOG9rVkFZQ012MUpGQ1pHdFhxb3NkajVnVTc3?oc=5", "source_name": "TradingView", "published_at": "2023-03-21T17:17:45+00:00", "published_display": "21 Mar 2023 17:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Health Catalyst (HCAT) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE41Y09CUldhX2hNZXRBakhfOHUtSVBWYmNmd2laT3FqWmVRNkdsWEktRTI2ZTN6NnR1emJQQkhFaHZRcTVzeVo0OGQySWxCQQ?oc=5", "source_name": "Stock Titan", "published_at": "2020-08-05T16:09:48+00:00", "published_display": "05 Aug 2020 16:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Mangoceuticals, Inc. \u2013 BOATS:MGRX", "summary": "This article provides financial information for Mangoceuticals, Inc. (MGRX), specifically focusing on its forward price-to-sales ratio. It appears to be a stub or a data-focused page from TradingView, indicating no trades and a closed market for the stock at the time of publicati", "url": "https://www.tradingview.com/symbols/BOATS-MGRX/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-12T20:11:13", "published_display": "12 Jul 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Mangoceuticals, Inc. \u2013 NASDAQ:MGRX", "summary": "This article provides the enterprise value to EBITDA forward for Mangoceuticals, Inc. (NASDAQ: MGRX) as displayed on TradingView. It highlights key financial metrics for MGRX, a company in the Pharmaceuticals: Major sub-sector. The data is supported by various financial and refer", "url": "https://www.tradingview.com/symbols/NASDAQ-MGRX/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T07:41:36", "published_display": "07 Jul 2026 07:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Mangoceuticals, Inc. \u2013 NASDAQ:MGRX", "summary": "The article presents the \"price to earnings forward\" metric for Mangoceuticals, Inc. (NASDAQ: MGRX). It shows the period, value, change, and percentage change for this financial indicator. The content is primarily a data display from TradingView, including various navigation and ", "url": "https://www.tradingview.com/symbols/NASDAQ-MGRX/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T09:10:35", "published_display": "06 Jul 2026 09:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Mangoceuticals, Inc. \u2013 NASDAQ:MGRX", "summary": "This article displays the title \"Enterprise value to revenue forward of Mangoceuticals, Inc. \u2013 NASDAQ:MGRX\" and some basic financial and market navigation information for Mangoceuticals, Inc. (MGRX). It shows that the market is closed with no trades, and provides links to overvie", "url": "https://www.tradingview.com/symbols/NASDAQ-MGRX/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T03:09:35", "published_display": "06 Jul 2026 03:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Mangoceuticals, Inc. Stocks", "summary": "This article lists ETFs that include Mangoceuticals, Inc. (MGRX) stocks in their holdings. It provides details on one specific ETF, the E Fund CSI Shanghai-Hong Kong-Shenzhen 500 ETF, including its market value, weight of MGRX, expense ratio, and performance. The information aims", "url": "https://www.tradingview.com/symbols/NASDAQ-MGRX/etfs/", "source_name": "TradingView", "published_at": "2026-07-04T03:11:10", "published_display": "04 Jul 2026 03:11", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals (MGRX) completes $272,000 private placement of common shares", "summary": "Mangoceuticals, Inc. (MGRX) has completed a private placement, selling 850,000 shares of restricted common stock to an accredited investor at $0.32 per share, totaling $272,000. The transaction, disclosed in an 8-K filing, includes piggyback registration rights for the investor f", "url": "https://www.stocktitan.net/sec-filings/MGRX/8-k-mangoceuticals-inc-reports-material-event-b680cbd4e52b.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:40:10", "published_display": "02 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals, Inc. announced that it has received $0.272 million in funding", "summary": "Mangoceuticals, Inc. has secured $0.272 million in funding through a subscription agreement with an accredited investor. The company issued 850,000 shares of restricted common stock at $0.32 per share, availing an exemption from registration under the securities act. This funding", "url": "https://www.marketscreener.com/news/mangoceuticals-inc-announced-that-it-has-received-0-272-million-in-funding-ce7f5fd3d181f423", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T16:11:10", "published_display": "29 Jun 2026 16:11", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trending Stocks Today | Mangoceuticals Soars 41.16% Post-Market", "summary": "Mangoceuticals (OTC: MNGOC) stock saw a significant 41.16% increase in post-market trading today, reaching $0.0031. This surge occurred despite the company not releasing any specific news or updates, suggesting market speculation or technical trading movements as potential driver", "url": "https://www.moomoo.com/news/post/71848625/trending-stocks-today-mangoceuticals-soars-41-16-post-market", "source_name": "Moomoo", "published_at": "2026-06-22T21:09:54", "published_display": "22 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MGRX Q3 2025 Earnings: EPS Loss of $0.69; Stock Declines 4.61% Amid Limited Data - Financial Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNcHlwa2xlNVN0X0Jqa2ROcUFqUEtneVhqWDhIYUxYUFIxa3ZvMk5iNWluWEVWRjF4MGFuT0VzMlE5ODVUeVBmZ2VUd2Rtb0VWYjZWYWFHSE1kTlZPLUMyTTROS1ZJUWNtLUtJdFdocnVhekdrN3BMa0NiYm1DUzBJb0xMNklJUVZIXzk1VDNEOEhLaEZ2emV6MWppWmdiYVk0enhnazAzaGpzWTZfRU9vRVctbXFndjlfM2htT2x0SjdGZw?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals Inc (MGRX) Institutional Confidence", "summary": "This article from TradingKey provides an overview of institutional confidence in Mangoceuticals Inc (MGRX), including its stock price, market cap, and various analytical dimensions. It details the institutional shareholding, listing key holders like Armistice Capital LLC and Cohe", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mgrx/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T21:40:39", "published_display": "18 Jun 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals Inc (MGRX) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "The article provides an overview of Mangoceuticals Inc (MGRX) stock, focusing on its dividend history and stock split events. It indicates that MGRX has not distributed dividends in the past five years and lists several merger events scheduled for October 11, 2024, with a 15:1 ra", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mgrx/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T13:10:22", "published_display": "17 Jun 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals Inc (MGRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article from TradingKey provides a revenue breakdown for Mangoceuticals Inc (MGRX), though it states that relevant data regarding business segments, regional revenue, and profit contribution have not yet been disclosed by the company. It briefly shows the stock's current mar", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mgrx/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T12:10:22", "published_display": "17 Jun 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MGRX Q3 2025 Earnings: Loss Per Share Pressures Stock as Revenue Remains Undisclosed - Peak Earnings Alert", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQakhtUm9DZlRSMGFJeFV6cThXb29EcGZSUFI4VXJBX2xUT1B5eVR3Zm9ZV25ndXhoaEFFTjNacnpXWTRya1l2YmxjVjlrVU1jQzhnbFBsSkt3MVN1YTROeEZVYlZZWXVlczFDZ3hJX2phX0NjeHJyVXdvSnRpNDNjY0owSHJWa3IwUTA4VVlDUVk0RFVDY0pRQ0hrMXVrWk1SbmlqSEZYT1p0aU9POXFONkZCRHhKX3V1VGdZZk1WV1lBSTg?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals (Nasdaq:MGRX) - Stock Analysis", "summary": "Mangoceuticals, Inc. (Nasdaq:MGRX) is a company specializing in men's wellness products and services delivered via a telemedicine platform. The stock analysis highlights significant risks including shareholder dilution, declining earnings and revenue, a small market capitalizatio", "url": "https://simplywall.st/stocks/us/consumer-retailing/nasdaq-mgrx/mangoceuticals", "source_name": "Simply Wall Street", "published_at": "2026-06-03T15:40:30", "published_display": "03 Jun 2026 15:40", "sentiment": "negative", "sentiment_pct": 8, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MGRX - Mangoceuticals Inc Stock Price and Quote", "summary": "This article provides a detailed overview of Mangoceuticals Inc. (MGRX) stock, including its current price, financial metrics, performance indicators, and recent news headlines. It covers market capitalization, sales, earnings per share, insider transactions, and a chronological ", "url": "https://finviz.com/stock?t=MGRX", "source_name": "Finviz", "published_at": "2026-06-01T15:10:35", "published_display": "01 Jun 2026 15:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MGRX Technical Analysis & Stock Price Forecast", "summary": "This article provides a technical analysis and stock price forecast for Mangoceuticals Inc (MGRX) as of June 1, 2026. It indicates an overall Neutral technical sentiment based on various indicators, with some suggesting buy and others sell. The analysis covers moving averages, mo", "url": "https://intellectia.ai/en/stock/MGRX/technical", "source_name": "Intellectia AI", "published_at": "2026-06-01T14:09:46", "published_display": "01 Jun 2026 14:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrightSpring Health Services (BTSG) Stock Analysis: Exploring Growth Amidst Strong Revenue Surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxORE9OaWtsRXhXVG1pb1k1OE55LTR4RXBWbUthTDBzSUMwdEZZcGdhUHNQdmFQeWIwbUlsYWNGZlVHVnNQTFF1Z0ZTUXBmME5tOVI1UjRtbTBkMC1Gc092TFRRUGpRaXJmMnhSTWRFS1FCYkIyeU1FbU5Hc1ZjOGtOZENWOUJuSEdjbGJIQjBPZmNhSy1GRVh1bTRDd0JKLWN3U0VoQi1YZEpjcTBKaUFvMzRxSENzUjdSR1VjT3o3V1gySXJXTHVTdzhzQ1NjWEMybnRNVHJIby1YanRt?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Number of shareholders of Mangoceuticals, Inc. \u2013 NASDAQ:MGRX", "summary": "This article displays the number of shareholders for Mangoceuticals, Inc. (NASDAQ: MGRX) as retrieved from TradingView. It provides a quick overview, but the specific numerical value for shareholders is not explicitly stated in the provided content. The article is part of Trading", "url": "https://www.tradingview.com/symbols/NASDAQ-MGRX/financials-statistics-and-ratios/number-of-shareholders/", "source_name": "TradingView", "published_at": "2026-05-30T17:08:53", "published_display": "30 May 2026 17:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals (NASDAQ: MGRX) Q1 2026 shows small sales, heavy loss and thin cash", "summary": "Mangoceuticals Inc. reported a Q1 2026 net loss of $3.4 million on revenues of $67,864, down from the prior year, with significant spending on operations and stock-based compensation. The company's cash and cash equivalents dwindled to $174,562, highlighting severe liquidity conc", "url": "https://www.stocktitan.net/sec-filings/MGRX/10-q-mangoceuticals-inc-quarterly-earnings-report-f99fc656b57e.html", "source_name": "Stock Titan", "published_at": "2026-05-20T08:39:50", "published_display": "20 May 2026 08:39", "sentiment": "negative", "sentiment_pct": 15, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MANGOCEUTICALS, INC. 1Q 2026: Revenue $67.9K, EPS $(0.22) \u2014 10-Q Summary", "summary": "MANGOCEUTICALS, INC. (MGRX) reported its first-quarter 2026 results, showing a revenue of $67.9K, a decrease from the prior year, and a net loss of $3.7M. Despite the revenue decline, the company narrowed its loss per share to $(0.22). Key business activities included advancing w", "url": "https://www.tradingview.com/news/tradingview:c76bab4add3ea:0-mangoceuticals-inc-1q-2026-revenue-67-9k-eps-0-22-10-q-summary/", "source_name": "TradingView", "published_at": "2026-05-19T20:39:50", "published_display": "19 May 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MGRX: Net loss narrowed but liquidity and Nasdaq compliance risks persist, requiring urgent funding", "summary": "MGRX experienced a decline in revenue and a narrowed net loss year-over-year, attributed to its focus on product testing and website development. However, the company faces ongoing financial losses, regulatory challenges, and Nasdaq compliance issues, underscoring an urgent need ", "url": "https://www.tradingview.com/news/urn:summary_document_report:quartr.com:3349304:0-mgrx-net-loss-narrowed-but-liquidity-and-nasdaq-compliance-risks-persist-requiring-urgent-funding/", "source_name": "TradingView", "published_at": "2026-05-19T20:39:50", "published_display": "19 May 2026 20:39", "sentiment": "negative", "sentiment_pct": 20, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals Delays Quarterly Filing After Audit Review", "summary": "Mangoceuticals, Inc. (MGRX) has announced a delay in filing its Form 10-Q for the quarter ended March 31, 2026, due to additional time required by its independent auditor for review. The company expects to file within the five-day grace period and does not anticipate significant ", "url": "https://www.tipranks.com/news/company-announcements/mangoceuticals-delays-quarterly-filing-after-audit-review", "source_name": "TipRanks", "published_at": "2026-05-15T23:09:11", "published_display": "15 May 2026 23:09", "sentiment": "negative", "sentiment_pct": 39, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals stock doubles after Texas lawsuit", "summary": "Mangoceuticals (MNGO) stock surged by an unspecified percentage following a legal victory in Texas. The company announced the successful resolution of its lawsuit against its former Chief Executive Officer. This news led to a significant increase in investor confidence and the st", "url": "https://www.msn.com/en-us/money/news/mangoceuticals-stock-doubles-after-texas-lawsuit/ar-AA1ZeNdH", "source_name": "MSN", "published_at": "2026-04-14T16:09:36", "published_display": "14 Apr 2026 16:09", "sentiment": "positive", "sentiment_pct": 95, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MGRX Q4 2025 Earnings Report on 4/1/2026", "summary": "This article details the Q4 2025 earnings report for Mangoceuticals (NASDAQ: MGRX), released on April 1, 2026. The company reported $0.13 Actual EPS and $0.09 million in Actual Revenue, with both consensus EPS and expected revenue listed as N/A. The report also highlights recent ", "url": "https://www.marketbeat.com/earnings/reports/2026-4-1-mangoceuticals-inc-stock/", "source_name": "MarketBeat", "published_at": "2026-04-01T13:39:44", "published_display": "01 Apr 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals 10-K: Revenue $0.456M, EPS loss $(2.17)", "summary": "Mangoceuticals (MGRX) reported annual revenue of $0.456 million and an EPS loss of $(2.17) for the year, primarily due to issues during a telemedicine platform relaunch. The company posted a significant net loss of $(20.643) million, driven by increased stock-based compensation, ", "url": "https://www.tradingview.com/news/tradingview:d1fb628062618:0-mangoceuticals-10-k-revenue-0-456m-eps-loss-2-17/", "source_name": "TradingView", "published_at": "2026-04-01T10:10:10", "published_display": "01 Apr 2026 10:10", "sentiment": "negative", "sentiment_pct": 30, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals Delays Annual 10-K Yearly Filing", "summary": "Mangoceuticals, Inc. (MGRX) has announced a delay in filing its 2025 Form 10-K Yearly Report, attributing the hold-up to its external auditor needing additional time for review. The company expects to file within the 15-day grace period from the original March 31, 2026 due date a", "url": "https://www.tipranks.com/news/company-announcements/mangoceuticals-delays-annual-10-k-yearly-filing", "source_name": "TipRanks", "published_at": "2026-04-01T02:10:10", "published_display": "01 Apr 2026 02:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MGRX SEC Filings - Mangoceuticals, Inc. 10-K, 10-Q, 8-K Forms", "summary": "This page on Stock Titan provides comprehensive access to Mangoceuticals, Inc. (MGRX) SEC filings, including annual reports (10-K), quarterly earnings (10-Q), and material events (8-K), along with insider trading forms. It details recent filings such as 8-K reports on stock place", "url": "https://www.stocktitan.net/sec-filings/MGRX/page-3.html", "source_name": "Stock Titan", "published_at": "2026-03-30T05:38:59", "published_display": "30 Mar 2026 05:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MGRX Mangoceuticals (NASDAQ) pre-market +99.81% Mar 24, 2026: watch heavy volume", "summary": "Mangoceuticals (MGRX) stock saw a significant pre-market surge of nearly 100% on heavy volume, driven by a recent patent filing, a lawsuit announcement, and strong retail interest. Despite this price action, the company's fundamentals indicate negative EPS and weak operating cash", "url": "https://meyka.com/blog/mgrx-mangoceuticals-nasdaq-pre-market-9981-mar-24-2026-watch-heavy-volume-2403/", "source_name": "Meyka", "published_at": "2026-03-24T09:10:08", "published_display": "24 Mar 2026 09:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals (MGRX) Stock Rockets 130% Following CEO\u2019s Substantial Share Award", "summary": "Shares of Mangoceuticals (MGRX) surged over 129% after SEC filings revealed CEO Jacob Cohen received a 500,000-share bonus and transferred an additional 200,000 shares to The Tiger Cub Trust. This comes amid exploding trading volumes and significant company activity including lit", "url": "https://www.mexc.com/news/974922", "source_name": "MEXC", "published_at": "2026-03-23T22:38:58", "published_display": "23 Mar 2026 22:38", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$MGRX stock is up 74% today. Here's what we see in our data.", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPd05VcFhmc3dYeHR4eV9HeGpHQXNheERXVk5wTzl1MjlvcnZYNm84dzJSbFI0aWpoall4WHNkWndKektDUEhHQ1JrX19ydHdpNWs4eXF3dkkwYjlMZ3owR1QxbndmRzdUMGx6QjhhUmRzQS1ucGthUzJqbHQ2UW9ta3RSVFpKeGxkY3V2UGZhZnhqLUZrYkJNX1JfY0g4REk2?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-02-20T08:00:00+00:00", "published_display": "20 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isn\u2019t the Only Problem.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPMTdzUkZQWG9tTW9zT3FxSWtzdkdLLUNYVkRJMDh2X1VRSlVrdmVkS3FCSVFpX210VUxVSUF1Q2FYakw1ZUxyQlpoZHZpM1RYQzBOYlpEWENxeGM1bXBZNFYxQjZRcFBpcS0tVVhRdzFTejBrVzU3aU9QQXdnYkZBMWxB?oc=5", "source_name": "Barron's", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxNQWRfTUpZV1VMWS0yT1pHZ2o3bmpPbWF2TnhCYldBUExuUmI5UnRZUGVVRGxDWTVveUlZZUo5Vm4wWE5md2k2Skt5YTlEVmJJV2pydWNrMFctTW9PSjFvekdqclhrSFpJYm5vVkQ4cjJlSi1BUV84ZjRBZlcyMFFQUW5zc1o?oc=5", "source_name": "Market source", "published_at": "2025-12-18T08:00:00+00:00", "published_display": "18 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals stock tumbles after Novo Nordisk, Lilly deny partnership claims", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQZEFuUzFWVFk3bGNrbDJVc0UyNHpvYUhSaXFNdC1TbW1CTGpFRUpTc21femZtV0JFMERQWVowSERQVVk2dl90MF9INDNzSmZBN1hiOC1WYV9kTTlqcVdOWVhpT1BoSmMtQVkxeTVTMXhwRFVWZWJKd1dwQkVva2stVkhJaFVZZVEyb0gyMGlWSTllQWlGeFhKdVFsbVBZVm01ZlZ4QndKLU9wTTB0NHl4UjAteWxGOV9vclViYnRIbVpJYWt3STF0VXEtdW5Iak1iX203aXl3?oc=5", "source_name": "Investing.com", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eco Science (ESSI) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5pdzBTRmxWRF9FdWNNTm9zUHp3cGVyeUtkRjNscHJKRWx0cUNkb2t5VTVsNXBNNDBXb3l2Qko1OXo2NXRfc0E5SjlvTVRyLUoycmlv?oc=5", "source_name": "Stock Titan", "published_at": "2025-09-18T22:26:50+00:00", "published_display": "18 Sep 2025 22:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TruBridge (TBRG) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBTeUEyaURoX1pUeXB4SEpSazZmal9VbGF2Qm8yWkVQZ2MwT3NzQTZkalRTRjdKcWM1YVA3TXpFOC1ZQ2lUWjdsM0QtNGFlNlhrLW1V?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T01:29:21+00:00", "published_display": "25 Apr 2025 01:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "VSee Health (VSEE) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE0ydzh1bEdnSnNlUEItUk5hZ0dGaV9yS2dscmFDa2tpT1ZFaGkwbzhLdUt3N3pfTnpHRlNVNE85N2J3cm4yajI4Zk9YbFpObW5aSnJV?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T18:07:28+00:00", "published_display": "24 Apr 2025 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Health Catalyst (HCAT) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9nVmdOdTFQYkVyaHJ6UW1DUWlITUZGdXlFY0l3dnZiNTk5djRlSFN0RFJkUHZ5RTMtU0VBMkJyZy1qb3ZsLUFyUmdFdWhiMDNaaVAw?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T17:33:44+00:00", "published_display": "24 Apr 2025 17:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Privia Health Group (PRVA) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFB2Z196b3pOYmd5QVVPUU9UakxZWllvaXozczRjR1lhaTh3eDBLS2NvcUhEU3g2TkxXNDh5SFg0a2ZXWkc4amZTRzc1QnJUM0hFRlFz?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T17:25:31+00:00", "published_display": "24 Apr 2025 17:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQUVQ0NVdGRzZjQXY5ZUdhVEFDbGVDaVdUbkd2bHhsdVZBMUx0T3NWMmVCUVhUMGRRNkdyaEtWeXpsR3FqY00wZlFqOU5DTkszUzQ2TWVCdWU3dzJCeWlXTzc1UURFZTZUWUtwQVM2MEJDSUtZQUhNZ0RvRnpXMENFbkZMWXMyVlhVQVVTclJwNVlHdjlyYWhIREJmOGJYbFE?oc=5", "source_name": "Market source", "published_at": "2024-12-04T08:00:00+00:00", "published_display": "04 Dec 2024 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "VSee Health (VSEE) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE9kdkZWQUJKUU1kT1hZb05MR2N1WmlnNktpY0Y1UDRJV3c3bWRtaU5QVEh4ZTZxbGF0TTdxTUFmSkh0cXR0UXpuM0xiNURCdw?oc=5", "source_name": "Stock Titan", "published_at": "2024-06-27T12:22:07+00:00", "published_display": "27 Jun 2024 12:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE1ZWGVRQlRLUEtvLTJIN01QMld5a3lpMnZSUWpjbzlrZWtqT0piN2c4U1BiVktEdm1pSTRTUnV2c1pPaTJvaDZEZ2xjVGpFeGZk?oc=5", "source_name": "CNN", "published_at": "2023-12-18T16:28:09+00:00", "published_display": "18 Dec 2023 16:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MGRX Stock Price and Chart \u2014 NASDAQ:MGRX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE4zZ1BXc2ZULWF4NE1tVjRxcG1VM0tiZmJVQ0ktb1k1LXlqaGNyV2lncldwcUVrRTg2Zml2TmRXWFpmOG9rVkFZQ012MUpGQ1pHdFhxb3NkajVnVTc3?oc=5", "source_name": "TradingView", "published_at": "2023-03-21T17:17:45+00:00", "published_display": "21 Mar 2023 17:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Health Catalyst (HCAT) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE41Y09CUldhX2hNZXRBakhfOHUtSVBWYmNmd2laT3FqWmVRNkdsWEktRTI2ZTN6NnR1emJQQkhFaHZRcTVzeVo0OGQySWxCQQ?oc=5", "source_name": "Stock Titan", "published_at": "2020-08-05T16:09:48+00:00", "published_display": "05 Aug 2020 16:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 84, "total_relevant": 47, "sentiment_summary": {"positive": 7, "negative": 9, "neutral": 31, "score": 49, "total": 47, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 75, "events": [{"event": "general", "label": "Market update", "weight": 11.0, "count": 20}, {"event": "earnings", "label": "Earnings", "weight": 10.6, "count": 18}, {"event": "guidance", "label": "Guidance", "weight": 1.65, "count": 3}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.65, "count": 3}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 7, "negative_events": 9}, "market_context": {"has_market_context": true, "latest_close": 0.36, "latest_week": "2026-07-10", "one_week_move": -22.3, "four_week_move": 2.3, "twelve_week_move": -16.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 1.028541, "market_dynamics_buy_signal": false, "relative_strength": -71.180901, "fair_value_gap": -91.0, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 48.0684, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-22.3% over one week, +2.3% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 57, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 10}, {"label": "Stock Titan", "count": 10}, {"label": "TradingKey", "count": 3}, {"label": "DirectorsTalk Interviews", "count": 2}, {"label": "TipRanks", "count": 2}, {"label": "Market source", "count": 2}, {"label": "www.marketscreener.com", "count": 1}, {"label": "Moomoo", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 47}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 20}, {"label": "Earnings", "count": 18}, {"label": "Guidance", "count": 3}, {"label": "Regulatory and legal", "count": 3}, {"label": "Deals and strategy", "count": 2}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "49/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "47", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-22.3% over one week, +2.3% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector"}], "updated_at": "2026-07-17T06:04:55.552678+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}